Form EFFECT Edesa Biotech, Inc.
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | July 13, 2026 4:05 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Parks Associates: Major Cable Providers Lost An Estimated 280,000 Broadband Subscribers In Q1 2026, Improving From An Estimated 320,000 Decline In Q1 2025
- Hawaii Department of Transportation Again Selects Telos Aviation Channeling Services for Aviation Worker Vetting Across Five Airports
- Momentum Launches New Vida E+ EX With Smarter Tech, Greater Comfort and Everyday Utility
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share